Ara
Toplam kayıt 6, listelenen: 1-6
Angio-seal used as a bailout for incomplete hemostasis after dual perclose ProGlide deployment in transcatheter aortic valve implantation
(Texas Heart Institute, 2022)
Background: The failure rate of vascular closure devices remains a significant cause of major vascular complications in contemporary transcatheter aortic valve implantation practice. Methods: This research aimed to evaluate ...
Is bioresorbable vascular scaffold acute recoil affected by baseline renal function and scaffold selection?
(Elsevier Ireland Ltd., 2016)
Objective: The aim of the present study was to investigate the relationship between glomerular filtration rate (GFR) and acute post-scaffold recoil (PSR) in patients undergoing bioresorbable scaffold (BVS) implantation. ...
Vascular complications after transcatheter transfemoral aortic valve implantation: Modified sheath-to-femoral artery ratio as a new predictor
(NLM (Medline), 2022)
OBJECTIVE: Vascular complications (VCs) contribute to increased morbidity and mortality in patients who have undergone transcatheter aortic valve implantation (TAVI); however, studies on their incidence and predictors show ...
Fragmented QRS on surface electrocardiography as a predictor of cardiac mortality in patients with SARS-CoV-2 infection
(Elsevier B.V., 2021)
Aims: Although severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is mainly a respiratory system disease, recent studies reported that cardiac injury is associated with poor outcomes in this population. ...
Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
(Termedia Publishing House Ltd., 2020)
Introduction: Elevated risk of adverse events in comparison to metallic stents resulted in withdrawal of everolimus-eluting bioresorbable scaffolds (eBVS), known as the most intensively studied BVS. There is a paucity of ...
How accurate are manufacturers' recommendations in determining ineligibility for transfemoral transcatheter aortic valve implantation?
(Sociedade Portuguesa De Cardiologia, 2023)
Introduction: Up to one-third of patients indicated for transcatheter aortic valve implantation (TAVI) may be unsuitable for transfemoral TAVI (TF-TAVI) according to manufacturers' recommendations and numerous professional ...